Quantitative proteomics of the miR-301a/SOCS3/STAT3 axis reveals underlying autism and anxiety-like behavior

Xun Li,Qi Fu,Mingtian Zhong,Yihao Long,Fengyun Zhao,Yanni Huang,Zizhu Zhang,Min Wen,Kaizhao Chen,Rongqing Chen,Xiaodong Ma

DOI: https://doi.org/10.1016/j.omtn.2024.102136

IF: 10.183

2024-02-04

Molecular Therapy — Nucleic Acids

Abstract:Autism is a widespread neurodevelopmental disorder. Although the research on ASD has been increasing in the past decade, there is still no specific answer to its mechanism of action and treatment. As a pro-inflammatory microRNA, miR-301a is abnormally expressed in various psychiatric diseases including autism. Here, we show that miR-301a deletion and inhibition exhibited two distinct abnormal behavioral phenotypes in mice. We observed that miR-301a deletion in mice impaired learning/memory, and enhanced anxiety. On the contrary, miR-301a inhibition effectively reduced the maternal immune activation (MIA) induced autism-like behaviors in mice. We further demonstrated that miR-301a bound to the 3'UTR region of the SOCS3, and that inhibition of miR-301a led to the upregulation of SOCS3 in hippocampus. The last result in the reduction of the inflammatory response by inhibiting phosphorylation of AKT and STAT3, and the expression level of IL-17A in poly(I:C)-induced autism-like features in mice. The obtained data revealed the miR-301a as a critical participant in partial behavior phenotypes, which may exhibit a divergent role between gene knockout and knockdown. Our findings ascertain that miR-301a negatively regulate SOCS3 in MIA-induced autism in mice, and could present a new therapeutic target for ameliorating the behavioral abnormalities of autism.

medicine, research & experimental